Martine Clozel - Actelion Ltd Insider

ALIOF -- USA Stock  

USD 278.50  0.00  0.00%

Founder, Chief Scientific Officer, Head of Drug Discovery Pharmacology and Preclinical Devel. and Sr. VP
Ms. Martine Clozel was Senior Vice President, Chief Scientific Officer, Head of Drug Discovery, Pharmacology Preclinical Development and Member of the Extended Actelion Executive Committee of Actelion Ltd since 2009. Prior to that, she was Senior Vice President, Head of Drug Discovery, Pharmacology Preclinical Development at the Company from 1997. She is one of the founders of the Company. She is Pediatrician specialized in neonatal intensive care, educated at Universite Henri Poincare Nancy I. She also took training in Physiology and pharmacology at McGill University, Montreal, and at University of California. She was Assistant Professor in Neonatology. She served at F. HoffmanLa Roche for 11 years.
Age: 60  Founder Since 2009      
41 61 565 65 65

Management Efficiency

The company has return on total asset (ROA) of 23.87 % which means that it generated profit of $23.87 on every $100 spent on asset. This is very large. Similarly, it shows return on equity (ROE) of 47.08 % meaning that it generated $47.08 on every $100 dollars invested by stockholders.

Entity Summary

Actelion Ltd, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs. Actelion Ltd (ALIOF) is traded on OTC Market in USA. It is located in Allschwil, and employs 2,500 people.

Actelion Ltd Leadership Team

Thomas Widman, Founder
Christian Albrich, President, MBA
Walter Fischli, President
Robert Bertolini, Director
Carl Feldbaum, Director
Andre Muller, President, MBA
John Greisch, Director, MBA
Rudi Frank, President, Ph.D
Marian Borovsky, SVP
Werner Henrich, Director
Nicholas Franco, President
Martine Clozel, Founder
Juhani Anttila, Director
JeanPierre Garnier, Chairman, MBA
David Stout, Director
JeanPaul Clozel, CEO
Guy Braunstein, President, Ph.D
Andrew Weiss, SVP, CFA
Herna Verhagen, Director
Michael Jacobi, Director, Ph.D
Jean Malo, Director, MBA
Otto Schwarz, COO, Ph.D
Roland Haefeli, President
Thomas Weller, President
Peter Gruss, Director, Ph.D

Stock Performance Indicators

Current Sentiment - ALIOF

Actelion Ltd Investor Sentiment
Most of Macroaxis users are presently bullish on Actelion Ltd. What is your sentiment towards investing in Actelion Ltd? Are you bullish or bearish?
98% Bullish
2% Bearish

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Actelion Ltd and Apple. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try CEO Directory module to screen ceos from public companies around the world.